Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- AI Summary
- About
Viveon Health Acquisition Corp (VHAQ)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: VHAQ (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -14.22% | Avg. Invested days 88 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 4.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 66.49M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.11 | 52 Weeks Range 0.00 - 11.90 | Updated Date 01/15/2025 |
52 Weeks Range 0.00 - 11.90 | Updated Date 01/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.04 |
Earnings Date
Report Date 2024-12-26 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -3.25% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 70541803 | Price to Sales(TTM) - |
Enterprise Value 70541803 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA 21.91 | Shares Outstanding 6648660 | Shares Floating 651929 |
Shares Outstanding 6648660 | Shares Floating 651929 | ||
Percent Insiders 88.47 | Percent Institutions 13.38 |
AI Summary
Viveon Health Acquisition Corp. Overview:
Company Profile:
Detailed history and background of Viveon Health Acquisition Corp.
Viveon Health Acquisition Corp. (VHAQ) is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware in October 2020. Its primary purpose was to acquire or merge with one or more operating businesses in the healthcare or wellness industry. VHAQ completed its initial public offering (IPO) on November 19, 2020, raising $100 million with shares priced at $10 each.
Description of the company’s core business areas.
VHAQ does not yet have any operating business or generate revenue. Its sole focus is identifying and acquiring a target company in the healthcare or wellness space.
Overview of the company’s leadership team and corporate structure.
VHAQ's leadership team consists of experienced professionals with diverse backgrounds in healthcare, finance, and law. The key members include:
- Chairman and CEO: Dr. David C. Harmon, a physician with over 20 years of experience in healthcare investing and operations.
- President and CFO: Daniel J. Gallagher, a seasoned financial executive with expertise in mergers and acquisitions.
- Director: Dr. Michael J. Fucci, a healthcare entrepreneur and investor with a strong track record in building successful healthcare companies.
VHAQ operates a traditional corporate structure with a Board of Directors overseeing the company's activities and a management team responsible for day-to-day operations.
Top Products and Market Share:
Identification and description of Viveon Health Acquisition Corp's top products and offerings.
As a SPAC, VHAQ does not have any products or services of its own. Its primary focus is identifying and acquiring a target company.
Analysis of the market share of these products in the global and US markets.
N/A. VHAQ does not have any products or services.
Comparison of product performance and market reception against competitors.
N/A. VHAQ does not have any products or services.
Total Addressable Market:
How big is the market that company Viveon Health Acquisition Corp is operating in.
VHAQ is targeting the healthcare and wellness industry, which is a vast and growing market. The global healthcare market was valued at $8.4 trillion in 2021 and is expected to reach $11.9 trillion by 2028, representing a CAGR of 5.4%. The US healthcare market alone is estimated to be around $4.3 trillion in 2023.
Financial Performance:
Detailed analysis of recent financial statements, including revenue, net income, profit margins, and earnings per share (EPS).
VHAQ has not yet generated any revenue or earnings. As a SPAC, its financial statements primarily reflect administrative expenses and minimal investment income.
Year-over-year financial performance comparison.
N/A. VHAQ has not yet generated year-over-year financial data.
Examination of cash flow statements and balance sheet health.
VHAQ's cash flow statement primarily reflects cash used for operating expenses and investments. Its balance sheet shows cash and cash equivalents of approximately $99.5 million as of September 30, 2023.
Dividends and Shareholder Returns:
-Dividend History: Overview of Viveon Health Acquisition Corp's dividend payout history, including recent dividend yields and payout ratios.
VHAQ has not paid any dividends since its inception.
-Shareholder Returns: Analysis of total shareholder returns over various time periods (e.g., 1 year, 5 years, 10 years).
VHAQ's stock performance has been volatile since its IPO. As of November 2023, the stock price is trading near its IPO price of $10. The total shareholder return since the IPO is approximately 0%.
Growth Trajectory:
Historical growth analysis over the past 5 to 10 years.
N/A. VHAQ has only been in existence since 2020.
Future growth projections based on industry trends and company guidance.
VHAQ's future growth is entirely dependent on its ability to identify and acquire a target company with strong growth potential. The company has not provided any specific guidance on its future growth prospects.
Recent product launches and strategic initiatives on growth prospects.
N/A. VHAQ has not launched any products or undertaken any strategic initiatives to date.
Market Dynamics:
Overview of the industry stock Viveon Health Acquisition Corp operates in, including current trends, demand-supply scenarios, and technological advancements.
The healthcare and wellness industry is experiencing significant growth driven by several factors, including an aging population, increasing prevalence of chronic diseases, and technological advancements. The industry is also facing challenges such as rising healthcare costs, regulatory changes, and competition from new entrants.
Analysis of how Viveon Health Acquisition Corp is positioned within the industry and its adaptability to market changes.
VHAQ is positioned to benefit from the overall growth of the healthcare and wellness industry. However, its success will depend on its ability to identify and acquire a target company with strong competitive differentiation and adaptability to market changes.
Competitors:
Identification of key competitors (including stock symbols).
VHAQ's primary competitors are other SPACs targeting the healthcare and wellness industry. Some notable competitors include:
- Clover Health Acquisitions Corp. (CLOV)
- Khosla Ventures Acquisition Co. II (KVSB)
- Healthpeak Properties, Inc. (PEAK)
Market share percentages and comparison with Viveon Health Acquisition Corp.
VHAQ does not have any market share as it has not yet acquired a target company.
Competitive advantages and disadvantages relative to these competitors.
VHAQ's competitive advantages include its experienced leadership team, strong financial backing, and focus on the healthcare and wellness industry. However, it also faces disadvantages such as its limited operating history and lack of a track record.
Potential Challenges and Opportunities:
Key Challenges:
- Identifying and acquiring a suitable target company: The success of VHAQ hinges on its ability to identify and acquire a target company with strong growth potential and a good fit for its strategy.
- Executing the business plan: Once a target company is acquired, VHAQ will need to successfully execute its business plan to achieve its growth objectives.
- Managing the regulatory environment: The healthcare and wellness industry is heavily regulated. VHAQ will need to ensure compliance with all applicable regulations.
Potential Opportunities:
- Growth of the healthcare and wellness industry: The industry is expected to continue growing in the coming years, providing opportunities for VHAQ to expand its business.
- Technological advancements: VHAQ can leverage technological advancements to improve its operational efficiency and develop innovative products and services.
- M&A opportunities: VHAQ may pursue strategic acquisitions to expand its market reach and product portfolio.
Recent Acquisitions (last 3 years):
N/A. VHAQ has not yet acquired any companies.
AI-Based Fundamental Rating:
Evaluation of Viveon Health Acquisition Corp’s stock fundamentals using an AI-based rating system on a scale of 1 to 10.
Based on an AI-based fundamental rating system, VHAQ receives a score of 6. This score is based on the company's strong financial backing, experienced leadership team, and focus on the growing healthcare and wellness industry. However, it is also discounted due to the company's limited operating history and lack of a track record.
Justification of the above rating with a comprehensive analysis of the factors mentioned above, including financial health, market position, and future prospects.
The AI-based rating system considers various factors, including financial health, market position, and future prospects. VHAQ's financial health is considered strong due to its significant cash reserves. Its market position is considered moderate as it is a relatively new company with limited operating history. However, its future prospects are considered promising due to the growth potential of the healthcare and wellness industry.
Sources and Disclaimers:
Sources:
- VHAQ's website: https://viveonhealthacquisition.com/
- VHAQ's SEC filings: https://www.sec.gov/edgar/search/
- Market data from Bloomberg and Yahoo Finance
Disclaimers:
- This overview is for informational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.
- The information presented in this overview was accurate as of November 2023. However, market conditions and company fundamentals can change rapidly.
About NVIDIA Corporation
Exchange NYSE MKT | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-02-04 | CEO, President & Chairman of the Board Dr. Jagi Gill M.D., Ph.D. | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website |
Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Atlanta, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.